To assess if these signaling alterations result in differences in tumor growth related to oncogenic capacity or immunity, we implanted P3CA-AR-V7 and P3CA-Empty cell lines into SCID and C57BL/6 mice. The gene discussed is AR; the disease is neoplasm.